Given the critical role of HuR in regulating the expression of tumor-related genes and the close association of its abnormal expression with the poor prognosis of patients, HuR has been regarded as a potential therapeutic target and a marker for therapeutic response and prognosis evaluation in CRC research (25). The gene discussed is ELAVL1; the disease is neoplasm.